LifeMD reports Q4 EPS 21c vs. 14c last year
PremiumThe FlyLifeMD reports Q4 EPS 21c vs. 14c last year
25d ago
LifeMD sees Q1 revenue $61M-$63M, consensus $59.6M
Premium
The Fly
LifeMD sees Q1 revenue $61M-$63M, consensus $59.6M
25d ago
LifeMD sees FY25 revenue $265M-$275M, consensus $258M
Premium
The Fly
LifeMD sees FY25 revenue $265M-$275M, consensus $258M
25d ago
LifeMD announces expansion into behavioral health market
PremiumThe FlyLifeMD announces expansion into behavioral health market
1M ago
Hims & Hers price target raised to $85 from $35 at BTIG
Premium
The Fly
Hims & Hers price target raised to $85 from $35 at BTIG
2M ago
LifeMD price target lowered to $7 from $10 at KeyBanc
Premium
The Fly
LifeMD price target lowered to $7 from $10 at KeyBanc
3M ago
LifeMD initiated with a Neutral at Mizuho
PremiumThe FlyLifeMD initiated with a Neutral at Mizuho
4M ago
ADA advises doctors, patients not to use compounded GLP-1s
Premium
The Fly
ADA advises doctors, patients not to use compounded GLP-1s
4M ago
Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s
Premium
The Fly
Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100